Nov 25, 2025 Economic Development Partnership Board
Economic Development Partnership Board · November 25, 2025
The Economic Development Partnership Board on Nov. 25, 2025 recommended that Denton City Council consider an incentive agreement to support Novartis Gene Therapies’ proposed radioligand therapy manufacturing facility at 2101 Shady Oaks, including up to $3.2 million in local incentives and an expected $280 million capital investment and 150–175 jobs.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.